Tag: Drug Screening
-
The Silent Revolution of Patient-Derived Organoids in Oncology
The Silent Revolution: Patient-D Derived Organoids in Oncology In modern oncology, a quiet revolution is unfolding. Patient-derived organoids, or PDOs, are three-dimensional cultures grown from a patient’s tumor tissue. They faithfully mirror the architecture, cellular diversity, and functional traits of the original tumor far better than traditional two-dimensional models. By recapitulating the tumor microenvironment, PDOs…
-
Silent Revolution in Oncology: The Rise of Patient-Derived Organoids
Introduction A quiet revolution is reshaping cancer research: patient‑derived organoids (PDOs) are elevating the study of tumors from flat, simplified systems to dynamic, three‑dimensional models that mirror the biology of individual cancers. Organoids are tiny, self‑organizing mini-tumors grown from a patient’s tissue or stem cells. In oncology, they recapitulate the architecture, genetic diversity, and microenvironment…